NWBO
Price:
$0.26
Market Cap:
$337.34M
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.[Read more]
Industry
Biotechnology
IPO Date
2001-12-14
Stock Exchange
PNK
Ticker
NWBO
According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.33. This represents a change of -44.71% compared to the average of -7.83 of the last 4 quarters.
The mean historical PE Ratio of Northwest Biotherapeutics, Inc. over the last ten years is -3.05. The current -4.33 PE Ratio has changed 14.11% with respect to the historical average. Over the past ten years (40 quarters), NWBO's PE Ratio was at its highest in in the June 2019 quarter at 163.32. The PE Ratio was at its lowest in in the March 2021 quarter at -75.40.
Average
-3.05
Median
-2.25
Minimum
-12.61
Maximum
3.41
Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 223.97%
Maximum Annual PE Ratio = 3.41
Minimum Annual Increase = -270.60%
Minimum Annual PE Ratio = -12.61
Year | PE Ratio | Change |
---|---|---|
2023 | -12.61 | 116.56% |
2022 | -5.82 | -270.60% |
2021 | 3.41 | -265.65% |
2020 | -2.06 | -59.00% |
2019 | -5.03 | 94.70% |
2018 | -2.58 | 223.97% |
2017 | -0.80 | 64.41% |
2016 | -0.48 | -77.64% |
2015 | -2.17 | -7.26% |
2014 | -2.34 | 24.09% |
The current PE Ratio of Northwest Biotherapeutics, Inc. (NWBO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-5.01
5-year avg
-4.42
10-year avg
-3.05
Northwest Biotherapeutics, Inc.’s PE Ratio is less than ImmunoCellular Therapeutics, Ltd. (0), greater than Celldex Therapeutics, Inc. (-10.81), less than CEL-SCI Corporation (-1.35), less than OncoSec Medical Incorporated (-0.01), less than Advaxis, Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
0 | $19.14M | |
-10.81 | $1.67B | |
-1.35 | $45.43M | |
-0.01 | $1.65M | |
-0.00 | $1.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Northwest Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Northwest Biotherapeutics, Inc. (NWBO)?
What is the highest PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 3-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 5-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
How does the current PE Ratio for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?